Low-Molecular–Weight Heparin Combined With Insulin Versus Insulin Alone in the Treatment of Hypertriglyceridemic Pancreatitis (LIHTGP Trial)
- DOI
- 10.1097/mpa.0000000000001697
- Published
- 2020-10-13
- Container
- Pancreas
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/mpa.0000000000001697,
title = {Low-Molecular–Weight Heparin Combined With Insulin Versus Insulin Alone in the Treatment of Hypertriglyceridemic Pancreatitis (LIHTGP Trial)},
author = {Bingjun Yu and Wenhua He and Cong He and Nianshuang Li and JiaRong Li and Yin Zhu and Youxiang Chen and Nonghua Lu},
year = {2020},
journal = {Pancreas},
doi = {10.1097/mpa.0000000000001697},
url = {https://doi.org/10.1097/mpa.0000000000001697}
}RIS
TY - JOUR TI - Low-Molecular–Weight Heparin Combined With Insulin Versus Insulin Alone in the Treatment of Hypertriglyceridemic Pancreatitis (LIHTGP Trial) AU - Bingjun Yu AU - Wenhua He AU - Cong He AU - Nianshuang Li AU - JiaRong Li AU - Yin Zhu AU - Youxiang Chen AU - Nonghua Lu PY - 2020 JO - Pancreas DO - 10.1097/mpa.0000000000001697 UR - https://doi.org/10.1097/mpa.0000000000001697 ER -
APA
Yu, B., He, W., He, C., Li, N., Li, J., Zhu, Y., Chen, Y., & Lu, N. (2020). Low-Molecular–Weight Heparin Combined With Insulin Versus Insulin Alone in the Treatment of Hypertriglyceridemic Pancreatitis (LIHTGP Trial). Pancreas. https://doi.org/10.1097/mpa.0000000000001697
Source records
- crossref · retrieved 2026-09-26T07:22:26.351Z